Author

L. Miarka

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1 Organism:mouse· 1 Assay:proteomics· 1

Frequent Co-Authors

A. Hernandez-Lain· 1 shared A. Perez-Nunez· 1 shared C. Blanco-Aparicio· 1 shared C. Nör· 1 shared D. Megias· 1 shared D. Retana· 1 shared E. Caleiras· 1 shared E. Hernandez-Encinas· 1 shared

Activity by Year

2020-2020 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. Hernandez-Lain

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

A drug-screening platform based on organotypic cultures identifies vulnerabilities to prevent local relapse and treat established brain metastasis

L. Zhu, N. Yebra, D. Retana, L. Miarka, E. Hernandez-Encinas, C. Blanco-Aparicio, S. Martinez, R. Soffietti, L. Bertero, P. Cassoni, T. Weiss, J. Munoz, J. M. Sepulveda, A. Perez-Nunez, A. Hernandez-Lain, , M. Valiente

The paper introduces a drug-screening platform using organotypic cultures to identify effective treatments for brain metastasis, finding a potent HSP90 inhibitor that works against mouse and human metastases.

bioRxiv · Oct 16, 2020 · PreprintCancer Biology